Apr 27, 2010

There's A New Drug To Help Guys Who "Finish" Too Soon



Last week, a study in the "Journal of Sexual Medicine" revealed that premature ejaculation might be GENETIC, and not because you're undisciplined or overeager. And now that you know it's not all your fault . . . here's a drug to help you. Classic.

(--To be technical about it, some say premature ejaculation is when a guy loses it within two minutes of "penetration." Others say the cutoff is six-and-a-half minutes.)

(--But it doesn't slow down as a guy gets older, and it might even speed up. Researchers say it has to do with a variation in a gene that controls the release of dopamine in our brains.)

(--Guys with the abnormality are much more likely to "finish" quickly. And since the gene variation was passed down in their DNA, their fathers and grandfathers were probably pretty disappointing between the sheets too.)


(--You can read the whole story from last week at the following link . . .)



--The new drug is called Priligy, and it hits the market today in the U.K. That makes it the world's first drug specifically designed to help guys who "finish" too soon.

--According to the makers, it increases the amount of serotonin in the brain, which helps a man have more control over his moment of release. If you pop a Priligy one to three hours before getting-it-on, you can last three times longer.

--But it's not cheap: Each pill costs $42 and you need a prescription. But it actually WORKS . . . unlike the cheap desensitizing creams and sprays they sell in sex shops, or thinking unsexy thoughts, which only works in movies.

--Priligy is already on sale in several other European countries, including Finland, Sweden, Austria, Portugal, and Germany. But here in the U.S. . . . well, we may not see it for a while.

--The Food and Drug Administration has already rejected it once because of a major side effect. By quickly raising your serotonin levels it acts as a brief anti-depressant . . . which can be bad for your body and mind in short bursts.

No comments: